SYSTEMATIC REVIEW article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1516407
This article is part of the Research TopicAdvances in skin immunologyView all 11 articles
Comorbidities in Primary Cicatricial Alopecia: A Systematic Review and Meta-Analysis
Provisionally accepted- Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Primary cicatricial alopecia (PCA) is known to be associated with various comorbidities; however, findings regarding the likelihood of specific comorbidities in PCA patients have been inconsistent. Objective: This study aimed to access the prevalence and odds of specific comorbidities in patients with PCA compared to controls, and to explore the distribution of comorbidities across various types of PCA. Methods: Electronic searches were conducted using PubMed, Embase, and Scopus from the dates of their inception until July 2024. A total of 116 studies with 33, 494 PCA patients that reported data allowing for the calculation of odds ratios (OR) or prevalences of certain comorbidities in PCA patients were included. Results: Systemic lupus erythematosus is more prevalent among patients with LPP [OR 3.10 (95% confidence interval: 2.24-4.29), prevalence 2%], FFA , prevalence 5%], and CCCA [OR 3.13 (1.03-9.49), prevalence 5%]. Hypothyroidism is more prevalent among patients with LPP [OR of 1.73 (1.24-2.42), prevalence 17%] and FFA [OR 1.86 (1.36-2.55), prevalence 19%]. LPP patients are prone to having dermatological diseases such atopic dermatitis [OR 3.96 (1.14-13.81), prevalence 9%], lichen planus [OR 19.21 (1.47-251.02), prevalence 8%], psoriasis [OR 4.75 (2.04-11.06), prevalence 3%], and rosacea ), prevalence 5%], while FFA patients are prone to having allergic contact dermatitis .08), prevalence 41%] and rosacea , prevalence 16%]. Coronary artery disease is found to be more common in LPP than controls ), prevalence 8%], while dyslipidemia is more common among FFA [OR 1.41 (1.06-1.88), prevalence 20%] and CCCA , prevalence 54%] than controls, and diabetes mellitus is more prevalent among CCCA than controls [OR 1.67 (1.03-2.69), prevalence 26%]. While skin cancer , prevalence 2%] and melanoma ), prevalence 1%] was found to be more common in LPP than controls, rheumatoid arthritis ), prevalence 4%] was found to be more common in FFA than controls, and allergic rhinitis , prevalence 24%] and anxiety ), prevalence 17%] were found to be more common in CCCA than controls. Conclusions: Patients with PCA are at higher risk of developing a wide range of comorbidities. Physicians should remain vigilant and conduct thorough investigations when clinical clues are present.
Keywords: scarring alopecia, Lichen planopilaris, Frontal fibrosing alopecia, central centrifugal cicatricial alopecia, Hair loss, immune-mediated alopecia, associated diseases, Autoimmune Diseases
Received: 24 Oct 2024; Accepted: 07 Aug 2025.
Copyright: © 2025 Yongpisarn, Tejapira and Suchonwanit. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Poonkiat Suchonwanit, Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.